Table 1.
Success rates of endoscopic treatment for primary VUR. Meta-analysis by Elder JS et al. 2006 summarizes results until 2003. More recent series are listed below. Initial success after one treatment and final success after two or more treatments.
| Reference | Bulking agent | Injected volume | Ureters | Follow-up | Success | |
|---|---|---|---|---|---|---|
| Initial | Final | |||||
| Elder et al. 2006 [27] | Various | 0.2–1.7 mL | 8101 | variable | 76% | 85% |
| Capozza et al. 2004 [33] | Various | 0.2–2.2 mL | 1694 | 12–204 months | 77% | |
| Kirsch et al. 2004 [5] | Dx/HA | 0.5–1.5 mL | 119 | 3–12 months | 92% | |
| Kirsch et al. 2006 [34] | Dx/HA | 0.8–2.0 mL | 139 | 3–18 months | 93% | |
| Van Capelle et al. 2004 [35] | PDMS | 0.2–2 mL | 311 | 3–110 months | 75% | |
| Kajbafzadeh et al. 2006 [36] | Ca hydroxylapatite | 0.4–0.6 mL | 364 | 6 months | 69% | |
| Yu and Roth 2006 [6] | Dx/HA | 1 mL | 162 | 2–26 months | 87% | 93% |
| Puri et al. 2006 [37] | Dx/HA | 0.2–1.5 mL | 1101 | 3–46 months | 87% | 96% |
| Lorenzo et al. 2006 [38] | PDMS | 351 | 72 months | 72% | ||
| Pinto et al. 2006 [39] | Dx/HA | 86 | 3 months | 84% | ||